Project Grant R01CA293927
Award Date
7/8/24
Completion Date
6/30/29
Dollars Obligated
$684K
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $432,304 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to The Trustees of Columbia University in the City of New York, Health Sciences Division, to develop enhanced cancer risk prediction models for underrepresented Black and Hispanic populations. The 5-year project, beginning January 3, 2025, aims to create novel data integration methods that effectively leverage diverse data sources, including electronic...
The National Cancer Institute (NCI) awarded a $696,140 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The Trustees of Columbia University in the City of New York, Health Sciences Division, to conduct a clinic-level cluster randomized trial. The study, titled "ICAN DEPCARE", aims to test the effectiveness of a multi-level implementation strategy to promote the uptake of evidence-based depression treatment among cancer patients with elevated depressive symptoms....
The National Cancer Institute (NCI) has awarded a $686,993 Cooperative Agreement under the Cancer Cause and Prevention Research Program (CFDA 93.393) to The Trustees of Columbia University in the City of New York to implement electronic health record (EHR)-based strategies and decision support for hereditary breast and ovarian cancer (HBOC) genetic testing among multiethnic women. The project aims to address the significant underutilization of HBOC genetic testing, particularly among women of...
This $541,682 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports research by the Trustees of Columbia University in New York to better understand the mechanisms underlying the 3D reorganization of the genome in cancer cells following DNA damage. The key objectives are to reveal how DNA repair domains assemble in 3D and evaluate the physiological and pathological consequences of this process, particularly...
This federal Project Grant award of $194,292 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) aims to investigate the mechanisms underlying lung cancer cell plasticity. The grant recipient, The Trustees of Columbia University in the City of New York, will leverage an innovative evolving lineage tracing model to quantitatively track cancer cell state transitions within the native tumor microenvironment. Specifically, the research will delineate cell-autonomous...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $193,144 to The Trustees of Columbia University in the City of New York to support a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers. The program aims to advance the understanding of GI cancers and reduce their morbidity and mortality by training the next generation of diverse GI cancer researchers. The 5-year award will support a...
This $505,613 Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) supports the development of statistical and computational approaches to utilize genomic data for precision cancer prevention at the Fred Hutchinson Cancer Center.
The key objectives are to: (1) develop deep learning-based methods to identify tumor subtypes associated with poor outcomes and integrate external biomarker data to improve risk prediction; and (2)...
This Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to evaluate the performance of four commercial mammography-based artificial intelligence (AI) algorithms for breast cancer risk prediction. The $989,122 award will fund a study using a large, diverse screening population to assess the accuracy and equity of these AI-based risk models compared to traditional clinical risk factor models. The study will be conducted at...
This Project Grant award of $146,868, provided by the National Institute of Environmental Health Sciences (NIEHS) under the Medical Library Assistance (CFDA 93.879) program, supports the development of a data visualization tool to inform cancer prevention and control efforts targeting low-income and underserved populations in South Carolina.
The key deliverables include: 1) A web-based interactive tool that utilizes South Carolina's integrated health database to identify colorectal, cervical,...
This federal Project Grant award of $723,513 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development, testing, and dissemination of the "Personalized Risk-Based Follow-Up of Cervical Cancer Screening in Practice" (PREDICT) intervention.
The PREDICT program aims to address barriers to implementing personalized, risk-based cervical cancer screening and management guidelines by developing a health IT-enabled, multi-level...